Manufacturing / Pharmaceutical Preparations
OPKO HEALTH, INC.
OPK
$1.38
+$0.01 (+0.37%)
Price as of Oct 9, 2026 19:38 UTC
1.1 B
Market Cap (Small Cap)
Oct 27
Next Earnings
Technical Signals
as of Oct 7
Bearish
1 of 7
Trend
- Above 20-day average $1.56
- Above 50-day average $1.52
- Above 200-day average $1.39 · +0.2%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 44d ago
Volume
- Below-average volume 1.0x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for OPK options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
35 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Rubin Steven D | Tax_withholding | 53,266 | $64,985 | +12.3% | |
| Jul 24, 2026 | Logal Adam | Tax_withholding | 53,266 | $64,985 | +12.3% | |
| Jun 18, 2026 | Yu Alice Lin-Tsing | Grant | 30,000 | $0 | -3.5% | |
| Jun 18, 2026 | UPPALURI SUBBARAO V | Grant | 80,000 | $0 | -3.5% | |
| Jun 18, 2026 | PAGANELLI JOHN A | Grant | 30,000 | $0 | -3.5% | |
| Jun 18, 2026 | PFENNIGER RICHARD C JR | Grant | 60,000 | $0 | -3.5% | |
| Jun 18, 2026 | Lachman Prem A | Grant | 30,000 | $0 | -3.5% | |
| Jun 18, 2026 | MEDEL ROGER MD | Grant | 30,000 | $0 | -3.5% | |
| Mar 20, 2026 | PAGANELLI JOHN A | Buy | 10,000 | $11,350 | +20.7% | |
| Mar 20, 2026 | PAGANELLI JOHN A | Other | 10,000 | $11,350 | +20.7% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Jul 30, 2026 | Q2 2026 | -$0.08 | |||
| Jul 29, 2026 | Q2 2026 | -$0.08 | |||
| Jul 27, 2026 | Q2 2026 | -$0.08 | |||
| Mar 31, 2026 | Q1 2026 | -$0.07 | -$0.07 | +1.0% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.07 | -$0.04 | +42.3% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.05 | $0.03 | +165.9% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.11 | -$0.19 | -65.9% | Miss |
Track OPK with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for OPK and your entire portfolio.